CD36 and cancer: The FAs enter the cancer cell through specific FA receptors and binding proteins (e.g., CD36, FATP1) and are used for membrane synthesis, energy metabolism, or lipid-derived cell signaling molecules (derivatives of arachidonic and linolenic acid).